Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$360K Sell
995
-100
-9% -$34.2K 0.1% 91
2026
Q1
$385K Buy
1,095
+9
+0.8% +$3.21K 0.13% 81
2025
Q4
$356K Buy
1,086
+27
+3% +$8.56K 0.14% 80
2025
Q3
$299K Buy
1,059
+51
+5% +$14.8K 0.13% 86
2025
Q2
$281K Sell
1,008
-47
-4% -$13.3K 0.13% 84
2025
Q1
$329K Buy
1,055
+5
+0.5% +$1.48K 0.16% 71
2024
Q4
$274K Sell
1,050
-20
-2% -$5.93K 0.13% 82
2024
Q3
$345K Hold
1,070
0.17% 70
2024
Q2
$334K Sell
1,070
-6
-0.6% -$1.76K 0.17% 65
2024
Q1
$306K Sell
1,076
-3
-0.3% -$878 0.16% 69
2023
Q4
$311K Buy
1,079
+9
+0.8% +$2.45K 0.18% 67
2023
Q3
$288K Buy
1,070
+3
+0.3% +$749 0.19% 70
2023
Q2
$237K Sell
1,067
-12
-1% -$2.78K 0.16% 82
2023
Q1
$261K Buy
1,079
+50
+5% +$12.3K 0.19% 71
2022
Q4
$270K Buy
+1,029
New +$276K 0.19% 61

Other funds holding AMGN

Cora Capital Advisors's AMGN Position: Q2 2026 in Review

Cora Capital Advisors reduced its Amgen (AMGN) stake by 9.1% in Q2 2026, selling an estimated $34.2K and leaving 995 shares worth $360K. The position accounts for 0.1% of the portfolio, ranked #91.

Cora Capital Advisors first reported a position in AMGN in Q4 2022 and has held it in 15 quarters since. The position peaked at $385K in Q1 2026. 1,372 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Cora Capital Advisors held 995 shares of Amgen worth $360K as of Q2 2026.
  • Cora Capital Advisors sold 100 Amgen shares in Q2 2026, an estimated $34.2K.
  • Amgen made up 0.1% of Cora Capital Advisors's portfolio in Q2 2026, its #91 holding.
  • Cora Capital Advisors first reported a position in Amgen in Q4 2022 and has held it in 15 quarters since.
  • Cora Capital Advisors's Amgen position peaked at $385K in Q1 2026.
  • 1,372 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Cora Capital Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.